| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |